文献速递产科母胎医学

血管生成因子单独或联合超声多普勒标准对晚发型小于胎龄儿合并或不合并子痫前期风险分类的研究

Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late-onset small fetuses with or without pre-eclampsia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-01-30

前瞻性队列研究纳入602例晚发型胎儿偏小孕妇,评估EFW、UtA-PI、CPR及sFlt-1/PlGF比值单独或联合预测不良围产结局的价值。sFlt-1/PlGF比值单独预测价值低,联合EFW后预测性能与EFW联合多普勒参数相似,联合全部参数检出率最高。

要点

  • sFlt-1/PlGF比值>第95百分位单独预测不良围产结局检出率39.8%,假阳性率16.9%。
  • EFW<第3百分位联合sFlt-1/PlGF比值检出率81.3%,联合EFW与多普勒参数检出率86.8%。
  • 合并子痫前期者仅sFlt-1/PlGF比值>第95百分位与不良围产结局独立相关。

核心结论

  • sFlt-1/PlGF比值单独预测不良围产结局价值低,联合EFW后预测性能与EFW联合多普勒参数相似。
  • 联合sFlt-1/PlGF比值、EFW及多普勒标准获得最高检出率,并可能有助于识别胎儿偏小妊娠中即将发生的子痫前期。
  • 作者认为这些发现支持将血管生成因子作为现有标准的附加指标用于识别晚发型胎儿偏小中的高危FGR,但不支持其作为独立生物标志物使用。

研究设计与样本

  • 前瞻性队列研究,纳入单胎妊娠、晚发型胎儿偏小(出生体重<第10百分位)且分娩时孕周≥34周的孕妇,共602例。
  • 每1-2周行超声评估EFW及多普勒评估UtA-PI和CPR;诊断SGA或FGR后1-2周内采用酶联免疫吸附法检测母体外周静脉血PlGF和sFlt-1。

主要发现

  • 602例中91例(15.1%)发生子痫前期,511例(84.9%)未发生。
  • 总体人群中,EFW<第3百分位aOR 2.58(95%CI 1.67-4.00)、UtA-PI>第95百分位aOR 1.92(95%CI 1.25-2.94)、CPR<第5百分位aOR 2.35(95%CI 1.46-3.78)、sFlt-1/PlGF比值>第95百分位aOR 1.71(95%CI 1.09-2.69)均与不良围产结局独立相关。
  • 合并子痫前期者仅sFlt-1/PlGF比值>第95百分位与不良围产结局独立相关;未合并子痫前期者仅EFW<第3百分位和CPR<第5百分位与不良围产结局独立相关。
  • 总体人群检出率与假阳性率:sFlt-1/PlGF比值>第95百分位单独为39.8%(95%CI 31.7-47.9%)与16.9%(95%CI 10.7-23.1%);EFW<第3百分位联合UtA-PI>第95百分位及CPR<第5百分位模型为86.8%(95%CI 83.4-90.2%)与61.9%(95%CI 57.1-66.7%);EFW<第3百分位联合sFlt-1/PlGF比值>第95百分位模型为81.3%(95%CI 77.3-85.3%)与52.3%(95%CI 47.1-57.5%);联合所有上述参数的模型为88.5%(95%CI 85.4-91.6%)与64.5%(95%CI 59.8-69.2%)。

临床怎么用

  • 作者认为血管生成因子可作为现有标准的附加指标用于识别晚发型胎儿偏小中的高危FGR,但不支持其作为独立生物标志物使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prognostic value of maternal angiogenic factors in late-onset small fetuses, alone or in combination with the ultrasound and Doppler parameters currently used for the classification of low-risk small-for-gestational-age (SGA) fetuses or high-risk fetal growth restriction (FGR), overall and according to the presence or absence of pre-eclampsia. METHODS: This was a prospective cohort study of women with a singleton pregnancy with a diagnosis of late-onset fetal smallness (defined as birth weight < 10th centile) and a gestational age of ≥ 34 weeks at delivery. Ultrasound assessment of estimated fetal weight (EFW) and Doppler assessment of uterine artery pulsatility index (UtA-PI) and cerebroplacental ratio (CPR) were performed every 1-2 weeks. Biochemical analysis of the angiogenic factors placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in maternal peripheral venous blood samples was performed using enzyme-linked immunosorbent assay within 1-2 weeks after diagnosis of SGA or FGR. The primary outcome was adverse perinatal outcome, defined as a composite of emergency Cesarean section for non-reassuring fetal status, metabolic acidosis (umbilical artery pH < 7.0), neonatal unit admission and/or perinatal death. The predictive value of EFW < 3rd centile, Doppler parameters (UtA-PI > 95th centile and CPR < 5th centile) and sFlt-1/PlGF ratio > 95th centile, alone or in combination, was assessed using logistic regression analysis in the overall population and stratified by presence or absence of pre-eclampsia developing at any time before delivery. RESULTS: Among the 602 included cases, 91 (15.1%) developed pre-eclampsia and 511 (84.9%) did not. In the overall study population, all parameters were associated independently with adverse perinatal outcome: EFW < 3rd centile (adjusted odds ratio (aOR), 2.58 (95% CI, 1.67-4.00)), UtA-PI > 95th centile (aOR, 1.92 (95% CI, 1.25-2.94)), CPR < 5th centile (aOR, 2.35 (95% CI, 1.46-3.78)) and sFlt-1/PlGF ratio > 95th centile (aOR, 1.71 (95% CI, 1.09-2.69)). Only sFlt-1/PlGF ratio > 95th centile was associated independently with adverse perinatal outcome in cases with pre-eclampsia, whereas in those without pre-eclampsia, only EFW < 3rd centile and CPR < 5th centile were associated independently with adverse perinatal outcome. In the overall population, the detection rate (DR) and false-positive rate for adverse perinatal outcome were, respectively: 39.8% (95% CI, 31.7-47.9%) and 16.9% (95% CI, 10.7-23.1%) for sFlt-1/PlGF ratio > 95th centile alone; 86.8% (95% CI, 83.4-90.2%) and 61.9% (95% CI, 57.1-66.7%) for a combined model of EFW < 3rd centile, UtA-PI > 95th centile and CPR < 5th centile; 81.3% (95% CI, 77.3-85.3%) and 52.3% (95% CI, 47.1-57.5%) for a combined model of EFW < 3rd centile and sFlt-1/PlGF ratio > 95th centile; and 88.5% (95% CI, 85.4-91.6%) and 64.5% (95% CI, 59.8-69.2%) for a combined model including all the abovementioned observed parameters. CONCLUSIONS: sFlt-1/PlGF ratio alone had a low predictive value for adverse perinatal outcome, but when combined with EFW, its predictive performance was similar to that of EFW combined with Doppler parameters. Combining sFlt-1/PlGF ratio with EFW and Doppler criteria achieved the highest DR for adverse perinatal outcome, and additionally, might help to identify imminent pre-eclampsia in pregnancies complicated by fetal smallness. These findings support the use of angiogenic factors as an additional criterion to those currently used for identifying high-risk FGR among late-onset small fetuses, but do not support their use as a standalone biomarker. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Youssef L, Crispi F, Paolucci S, et al. Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late-onset small fetuses with or without pre-eclampsia. Ultrasound Obstet Gynecol. 2025. PMID: 39888184. doi:10.1002/uog.29181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。